Cargando…

Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)

BACKGROUND: amyloid-PET reading has been classically implemented as a binary assessment, although the clinical experience has shown that the number of borderline cases is non negligible not only in epidemiological studies of asymptomatic subjects but also in naturalistic groups of symptomatic patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Chincarini, A., Peira, E., Morbelli, S., Pardini, M., Bauckneht, M., Arbizu, J., Castelo-Branco, M., Büsing, K.A., de Mendonça, A., Didic, M., Dottorini, M., Engelborghs, S., Ferrarese, C., Frisoni, G.B., Garibotto, V., Guedj, E., Hausner, L., Hugon, J., Verhaeghe, J., Mecocci, P., Musarra, M., Queneau, M., Riverol, M., Santana, I., Guerra, U.P., Nobili, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514268/
https://www.ncbi.nlm.nih.gov/pubmed/31077984
http://dx.doi.org/10.1016/j.nicl.2019.101846
_version_ 1783417862112673792
author Chincarini, A.
Peira, E.
Morbelli, S.
Pardini, M.
Bauckneht, M.
Arbizu, J.
Castelo-Branco, M.
Büsing, K.A.
de Mendonça, A.
Didic, M.
Dottorini, M.
Engelborghs, S.
Ferrarese, C.
Frisoni, G.B.
Garibotto, V.
Guedj, E.
Hausner, L.
Hugon, J.
Verhaeghe, J.
Mecocci, P.
Musarra, M.
Queneau, M.
Riverol, M.
Santana, I.
Guerra, U.P.
Nobili, F.
author_facet Chincarini, A.
Peira, E.
Morbelli, S.
Pardini, M.
Bauckneht, M.
Arbizu, J.
Castelo-Branco, M.
Büsing, K.A.
de Mendonça, A.
Didic, M.
Dottorini, M.
Engelborghs, S.
Ferrarese, C.
Frisoni, G.B.
Garibotto, V.
Guedj, E.
Hausner, L.
Hugon, J.
Verhaeghe, J.
Mecocci, P.
Musarra, M.
Queneau, M.
Riverol, M.
Santana, I.
Guerra, U.P.
Nobili, F.
author_sort Chincarini, A.
collection PubMed
description BACKGROUND: amyloid-PET reading has been classically implemented as a binary assessment, although the clinical experience has shown that the number of borderline cases is non negligible not only in epidemiological studies of asymptomatic subjects but also in naturalistic groups of symptomatic patients attending memory clinics. In this work we develop a model to compare and integrate visual reading with two independent semi-quantification methods in order to obtain a tracer-independent multi-parametric evaluation. METHODS: We retrospectively enrolled three cohorts of cognitively impaired patients submitted to (18)F-florbetaben (53 subjects), (18)F-flutemetamol (62 subjects), (18)F-florbetapir (60 subjects) PET/CT respectively, in 6 European centres belonging to the EADC. The 175 scans were visually classified as positive/negative following approved criteria and further classified with a 5-step grading as negative, mild negative, borderline, mild positive, positive by 5 independent readers, blind to clinical data. Scan quality was also visually assessed and recorded. Semi-quantification was based on two quantifiers: the standardized uptake value (SUVr) and the ELBA method. We used a sigmoid model to relate the grading with the quantifiers. We measured the readers accord and inconsistencies in the visual assessment as well as the relationship between discrepancies on the grading and semi-quantifications. CONCLUSION: It is possible to construct a map between different tracers and different quantification methods without resorting to ad-hoc acquired cases. We used a 5-level visual scale which, together with a mathematical model, delivered cut-offs and transition regions on tracers that are (largely) independent from the population. All fluorinated tracers appeared to have the same contrast and discrimination ability with respect to the negative-to-positive grading. We validated the integration of both visual reading and different quantifiers in a more robust framework thus bridging the gap between a binary and a user-independent continuous scale.
format Online
Article
Text
id pubmed-6514268
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-65142682019-05-20 Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC) Chincarini, A. Peira, E. Morbelli, S. Pardini, M. Bauckneht, M. Arbizu, J. Castelo-Branco, M. Büsing, K.A. de Mendonça, A. Didic, M. Dottorini, M. Engelborghs, S. Ferrarese, C. Frisoni, G.B. Garibotto, V. Guedj, E. Hausner, L. Hugon, J. Verhaeghe, J. Mecocci, P. Musarra, M. Queneau, M. Riverol, M. Santana, I. Guerra, U.P. Nobili, F. Neuroimage Clin Regular Article BACKGROUND: amyloid-PET reading has been classically implemented as a binary assessment, although the clinical experience has shown that the number of borderline cases is non negligible not only in epidemiological studies of asymptomatic subjects but also in naturalistic groups of symptomatic patients attending memory clinics. In this work we develop a model to compare and integrate visual reading with two independent semi-quantification methods in order to obtain a tracer-independent multi-parametric evaluation. METHODS: We retrospectively enrolled three cohorts of cognitively impaired patients submitted to (18)F-florbetaben (53 subjects), (18)F-flutemetamol (62 subjects), (18)F-florbetapir (60 subjects) PET/CT respectively, in 6 European centres belonging to the EADC. The 175 scans were visually classified as positive/negative following approved criteria and further classified with a 5-step grading as negative, mild negative, borderline, mild positive, positive by 5 independent readers, blind to clinical data. Scan quality was also visually assessed and recorded. Semi-quantification was based on two quantifiers: the standardized uptake value (SUVr) and the ELBA method. We used a sigmoid model to relate the grading with the quantifiers. We measured the readers accord and inconsistencies in the visual assessment as well as the relationship between discrepancies on the grading and semi-quantifications. CONCLUSION: It is possible to construct a map between different tracers and different quantification methods without resorting to ad-hoc acquired cases. We used a 5-level visual scale which, together with a mathematical model, delivered cut-offs and transition regions on tracers that are (largely) independent from the population. All fluorinated tracers appeared to have the same contrast and discrimination ability with respect to the negative-to-positive grading. We validated the integration of both visual reading and different quantifiers in a more robust framework thus bridging the gap between a binary and a user-independent continuous scale. Elsevier 2019-05-04 /pmc/articles/PMC6514268/ /pubmed/31077984 http://dx.doi.org/10.1016/j.nicl.2019.101846 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Chincarini, A.
Peira, E.
Morbelli, S.
Pardini, M.
Bauckneht, M.
Arbizu, J.
Castelo-Branco, M.
Büsing, K.A.
de Mendonça, A.
Didic, M.
Dottorini, M.
Engelborghs, S.
Ferrarese, C.
Frisoni, G.B.
Garibotto, V.
Guedj, E.
Hausner, L.
Hugon, J.
Verhaeghe, J.
Mecocci, P.
Musarra, M.
Queneau, M.
Riverol, M.
Santana, I.
Guerra, U.P.
Nobili, F.
Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)
title Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)
title_full Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)
title_fullStr Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)
title_full_unstemmed Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)
title_short Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)
title_sort semi-quantification and grading of amyloid pet: a project of the european alzheimer's disease consortium (eadc)
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514268/
https://www.ncbi.nlm.nih.gov/pubmed/31077984
http://dx.doi.org/10.1016/j.nicl.2019.101846
work_keys_str_mv AT chincarinia semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT peirae semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT morbellis semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT pardinim semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT baucknehtm semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT arbizuj semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT castelobrancom semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT busingka semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT demendoncaa semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT didicm semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT dottorinim semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT engelborghss semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT ferraresec semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT frisonigb semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT garibottov semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT guedje semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT hausnerl semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT hugonj semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT verhaeghej semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT mecoccip semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT musarram semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT queneaum semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT riverolm semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT santanai semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT guerraup semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc
AT nobilif semiquantificationandgradingofamyloidpetaprojectoftheeuropeanalzheimersdiseaseconsortiumeadc